Smisson-Cartledge Biomedical

Founded in 1996, Smisson-Cartledge Biomedical is a medical device company dedicated to developing therapeutic solutions for thermal infusion care. Their core mission is to enhance patient outcomes through innovative medical technologies. The company's flagship product, the ThermaCor 1200 infusion system, is a portable device designed for various medical procedures, including hypothermia treatment, resuscitation, cardiac and transplant surgeries, and cancer treatment. Smisson-Cartledge Biomedical primarily focuses on the healthcare market, providing critical care solutions to hospitals and medical professionals.

Notable affiliated individuals include the founders, Dr. Fred Smisson and Dr. Robert Cartledge, who are key figures in the medical field. The company has attracted significant interest from investors in the healthcare sector due to its innovative approach and impactful products. Key achievements include the widespread adoption of the ThermaCor 1200 in critical care settings and recognition for improving patient care standards. Overall, Smisson-Cartledge Biomedical has made a substantial impact on the medical device industry by offering life-saving technologies that address critical clinical needs.